시장 데이터 로딩 중...
2026년 8월 29일 토요일
홈으로Korea Stock전체 Hanmi Semiconductor 기사

Hanmi Semiconductor (042700.KS) FY2025 Financial Analysis: Cash Surges 166% as HBM Equipment Dominates

작성자 MinJeKim3 조회

이 기사의 한국어 번역이 준비 중입니다. 아래는 영어 원문입니다.

Hanmi Semiconductor (042700.KS) FY2025 Financial Analysis: Cash Surges 166% as HBM Equipment Dominates

Hanmi Semiconductor (042700.KS)

FY2025 Financial Analysis: Cash Surges 166% as HBM Equipment Dominates

Source: Hanmi Semiconductor Annual Report (46th FY) — Filed March 12, 2026 | Consolidated Financial Statements | Unit: KRW millions

Published: April 9, 2026 | By LineVest Editorial Team

Hanmi Semiconductor posted consolidated revenue of ₩576.7 billion in FY2025, up 3.2% year-on-year, as its HBM TC Bonder franchise continued to anchor demand from leading memory chipmakers. While top-line growth moderated from FY2024's explosive 251% surge, the company demonstrated exceptional cash generation, balance sheet strengthening, and margin resilience — cementing its position as one of Korea's premier semiconductor equipment makers.

📊 Key Financial Highlights at a Glance

MetricFY2023FY2024FY2025YoY Change
Revenue₩159.0B₩558.9B₩576.7B▲3.2%
Gross Profit₩79.4B₩314.5B₩332.0B▲5.6%
Gross Margin49.9%56.3%57.6%▲130bps
Operating Income₩56.7B₩255.5B₩251.4B▼1.6%
Operating Margin35.7%45.7%43.6%▼210bps
Net Income₩311.0B*₩152.7B₩214.0B▲40.2%
EPS (₩)₩3,216*₩1,589₩2,256▲42.0%
Cash & Equiv.₩179.7B₩104.0B₩276.2B▲165.6%

1. Revenue and Profitability

Revenue growth decelerated sharply to 3.2% following FY2024's 251% breakout year, driven by concentrated HBM TC Bonder orders. This normalization reflects a higher base effect rather than weakening demand — confirmed by robust advance receipts of ₩68.4B, a 3.6x increase year-over-year, signaling strong FY2026 order intake.

More telling is the gross margin expansion to 57.6%, the highest in the company's three-year history. This was achieved by optimizing the outsourcing mix: cutting external manufacturing by 48.6% while maintaining in-house efficiencies.

Operating income edged down 1.6% to ₩251.4B, with an operating margin of 43.6% versus 45.7% in FY2024. The culprit was a 36.1% surge in SG&A expenses to ₩80.6B, reflecting headcount growth, Singapore subsidiary establishment, and patent litigation costs.

Net income rebounded sharply to ₩214.0B (+40.2%), despite slightly lower operating earnings. The gap is explained by a ₩74.5B swing in non-operating income — driven by a ₩73.8B gain from cancellation of treasury shares.

Margin Analysis

MarginFY2023FY2024FY2025
Gross Margin49.9%56.3%57.6%
Operating Margin35.7%45.7%43.6%
Net Margin195.6%*27.3%37.1%

* FY2023 net margin distorted by ~₩207.1B one-off financial asset valuation gains.

2. Cost Structure: Fixed vs. Variable

Total operating costs reached ₩325.3B. The cost base is split across three categories:

Cost TypeFY2025 (₩B)YoY ChangeKey Driver
Fixed Costs (COGS)₩201.0B▼1.0%In-house manufacturing stable
Semi-Variable Costs (SG&A)₩80.6B▲36.1%Headcount, Singapore subsidiary, legal
Variable Costs (Outsourcing)₩43.7B▼4.2%Outsourcing cut by 48.6%

The most notable shift was in semi-variable costs, which surged 119% to ₩39.2B. Service fees alone jumped 61.9% to ₩23.9B, reflecting expanded global sales infrastructure including a new Singapore subsidiary. Variable costs fell 4.2% as outsourcing was cut by nearly half (-48.6%) — the primary driver of gross margin improvement.

3. Balance Sheet: Debt-Free, Cash-Rich

ItemFY2025FY2024FY2023
Cash & Equivalents₩276.2B₩104.0B₩179.7B
Accounts Receivable₩62.4B₩146.9B₩40.6B
Inventory₩150.4B₩153.4B₩95.4B
PP&E & Inv. Property₩246.9B₩183.7B₩135.7B
Intangible Assets₩23.3B₩4.6B₩4.5B
Total Assets₩813.3B₩710.9B₩726.9B
Short-term Borrowings₩0B₩0B₩0B
Total Equity₩694.3B₩618.7B₩677.3B

Total assets grew to ₩813.3B on the back of a 166% surge in cash to ₩276.2B — a record high. With zero borrowings at year-end, the company carries no financial debt, giving it maximum flexibility for capital allocation. Advance receipts of ₩68.4B confirm robust order visibility heading into FY2026.

4. Cash Flow Analysis

CF CategoryFY2025 (₩B)FY2024 (₩B)FY2023 (₩B)
Operating CF₩228.6B₩152.9B₩43.8B
Investing CF+₩18.3B-₩86.1B-₩36.8B
Financing CF-₩77.2B-₩231.7B-₩24.1B
Net Change in Cash+₩172.2B-₩164.9B-₩17.1B

Operating CF hit ₩228.6B — more than five times FY2023's level — driven by ₩85.4B in accounts receivable collections and ₩37.9B in inventory optimization. This reflects the high cash conversion quality of Hanmi's business model.

Investing CF turned positive at +₩18.3B, but this masks an acceleration in capital investment. CAPEX jumped 39.4% to ₩74.5B — directed at new equipment lines and intangible asset development (up ₩19.1B) — while financial asset disposals generated ₩112.4B in inflows.

Financing outflows contracted sharply from ₩231.7B to ₩77.2B. Share buybacks were scaled back to ₩7.8B (vs. ₩189.9B in FY2024) while dividends were raised 68.5% to ₩68.3B. Prior period buybacks totaling ₩130.3B in treasury shares were cancelled, delivering permanent per-share value accretion.

5. Key Takeaways and Outlook

Hanmi Semiconductor enters FY2026 in its strongest financial position to date — debt-free, with record cash, industry-leading margins, and an expanding product portfolio targeting HBM6, 2.5D AI packaging, and hybrid bonding platforms.

Key Risks

  • Customer concentration — SK Hynix dependency remains the central demand risk
  • SG&A creep — a 36% cost increase against only 3% revenue growth compresses operating leverage
  • WIDE TC Bonder ramp timing — commercialization delay would affect FY2026 order momentum

Upside Drivers

  • Advance receipts up 3.6x signal strong order intake heading into FY2026
  • Intangible investment surge (₩19.1B) reflects pipeline breadth across hybrid bonder and 2.5D packaging
  • Zero-debt balance sheet with record ₩276.2B cash provides full flexibility for accelerated R&D or M&A
  • EPS of ₩2,256 in FY2025 (+42.0% YoY) reflects strong per-share earnings growth
DimensionAssessmentSignal
Revenue QualityHigh — HBM-linked, advance-receipt backed🟢 Strong
Margin ProfileBest-in-class at 57.6% gross, 43.6% operating🟢 Strong
Balance SheetZero debt, record ₩276B cash🟢 Strong
Cash ConversionOperating CF / Net Income = 106.8%🟢 Strong
Cost DisciplineSG&A +36% vs. Revenue +3%🟡 Watch
Customer RiskConcentrated in SK Hynix🟡 Watch

Disclaimer: This report is for informational purposes only and does not constitute investment advice. All figures sourced from publicly disclosed financial statements. Past performance is not indicative of future results.

헤드라인 너머를 읽으세요

방금 '무슨 일이 있었는지' 읽으셨습니다. 이제 '그게 무엇을 의미하는지' 읽어보세요.

무료 데일리 브리핑

매일 아침 미국 시장을 — 무료로

LineVest Daily가 개장 전 받은편지함에 도착합니다: 미국 증시 핵심 스토리, 실적, 공시, 외국인 수급 — 쉬운 영어로. 무료, 카드 등록 불필요.

LineVest Daily 무료 구독 →
이 기업

Hanmi Semiconductor 전체 리포트

Hanmi Semiconductor의 최신 SEC 공시를 전부 읽고 분석합니다 — US GAAP 재무, 지배구조, 그리고 주가에 갖는 의미까지. 3시간 이내 PDF로 발송.

$12 · 1회

Hanmi Semiconductor 리포트 받기
관심 종목 전부

시장 전체를 팔로우하세요

매주 여러 미국 종목을 보시나요? 모든 분석 기사를 발행 즉시 읽으세요 — 데일리 미국 증시 전체 커버리지와 90일 아카이브까지.

$9.99 · 월

구독하기

1차 출처인 SEC 공시에 기반한 독립 저널리즘 — 투자 자문이 아닙니다. 어떤 증권사와도 무관합니다.

관련 기사

How to Read Korean DART Filings in English: A Guide for Foreign Investors
기업 분석

How to Read Korean DART Filings in English: A Guide for Foreign Investors

삼성전자 2026년 2분기: 영업이익 89.5조 원 사상 최대, MX는 2011년 이후 첫 분기 적자
기업 분석

삼성전자 2026년 2분기: 영업이익 89.5조 원 사상 최대, MX는 2011년 이후 첫 분기 적자

셀트리온, 2026년 2분기 실적 공시 정정…영업이익 4,300억 원 사상 최대 확인
기업 분석

셀트리온, 2026년 2분기 실적 공시 정정…영업이익 4,300억 원 사상 최대 확인

기업 분석

에이비엘바이오 Q1 2026: 현금 1,867억 확보·적자 47% 축소, 계약부채 460억 매출 버팀목

이오테크닉스 (039030) Q1 2026: 매출 1,151억 +35.7%, 영업이익 두 배 급증 — 반도체 레이저 슈퍼사이클 진입
기업 분석

이오테크닉스 (039030) Q1 2026: 매출 1,151억 +35.7%, 영업이익 두 배 급증 — 반도체 레이저 슈퍼사이클 진입

삼천당제약 FY2025: 아일리아 바이오시밀러 첫 수출로 영업이익 220% 급증, 흑자전환
기업 분석

삼천당제약 FY2025: 아일리아 바이오시밀러 첫 수출로 영업이익 220% 급증, 흑자전환

OCI홀딩스 (010060.KS) 2026년 2분기: 텍사스 태양광 호조로 매출 58% 급증·3분기 연속 흑자
기업 분석

OCI홀딩스 (010060.KS) 2026년 2분기: 텍사스 태양광 호조로 매출 58% 급증·3분기 연속 흑자

코오롱티슈진 (950160) Q1 2026: 순손실 999억 대부분이 비현금 파생손실 — 개발비 3,558억이 진짜 관건
기업 분석

코오롱티슈진 (950160) Q1 2026: 순손실 999억 대부분이 비현금 파생손실 — 개발비 3,558억이 진짜 관건

주성엔지니어링 (036930.KQ) 2026년 1분기: 매출 절반 토막 ₩549억, R&D 비중 46%로 영업손실 ₩70억
기업 분석

주성엔지니어링 (036930.KQ) 2026년 1분기: 매출 절반 토막 ₩549억, R&D 비중 46%로 영업손실 ₩70억

레인보우로보틱스(277810.KQ) 2026년 1분기: 삼성전자 지원 효과로 매출 116.6% 급증, R&D 집중도 확대로 영업손실 증가
기업 분석

레인보우로보틱스(277810.KQ) 2026년 1분기: 삼성전자 지원 효과로 매출 116.6% 급증, R&D 집중도 확대로 영업손실 증가

알테오젠 (196170.KQ) 2026년 1분기: SG&A 120% 급증으로 영업이익 36% 감소, 바이오젠 8,675억원 계약 체결
기업 분석

알테오젠 (196170.KQ) 2026년 1분기: SG&A 120% 급증으로 영업이익 36% 감소, 바이오젠 8,675억원 계약 체결

에코프로 (086520.KQ) 2026년 1분기: ₩2,473억 손익 급반전, 매출총이익률 2배 상승
기업 분석

에코프로 (086520.KQ) 2026년 1분기: ₩2,473억 손익 급반전, 매출총이익률 2배 상승